AAAAAA
Results:
1-22
|
Results: 22
Authors:
BURNETT AK
GOLDSTONE A
HANN I
STEVENS R
REES JKH
WHEATLEY K
Citation: Ak. Burnett et al., EVALUATION OF STEM-CELL TRANSPLANTATION IN AML, Leukemia & lymphoma (Print), 30, 1998, pp. 29-29
Authors:
GRIMWADE D
LANGABEER S
HOWE K
WALKER H
WHEATLEY K
HARRISON G
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., THE ROLE OF MOLECULAR DIAGNOSIS AND RESIDUAL DISEASE MONITORING IN APL - RESULTS OF THE MRC ATRA TRIAL, British Journal of Haematology, 101, 1998, pp. 322-322
Authors:
GRIMWADE D
WALKER H
OLIVER F
WHEATLEY K
HARRISON C
HARRISON G
REES J
HANN I
STEVENS R
BURNETT A
GOLDSTONE A
Citation: D. Grimwade et al., THE IMPORTANCE OF DIAGNOSTIC CYTOGENETICS ON OUTCOME IN AML - ANALYSIS OF 1,612 PATIENTS ENTERED INTO THE MRC-AML-10 TRIAL, Blood, 92(7), 1998, pp. 2322-2333
Authors:
GOLDSTONE A
REEVE D
LEVINSON D
VACHRANUKUNKIET T
Citation: A. Goldstone et al., USING COMPUTERIZED TEST-RESULTS TO DEVELOP REHABILITATION PLANS FOR STROKE PATIENTS, Archives of clinical neuropsychology, 12(4), 1997, pp. 325-325
Authors:
GRIMWADE D
WALKER H
OLIVER F
WHEATLEY K
CLACK R
BURNETT A
GOLDSTONE A
Citation: D. Grimwade et al., WHAT HAPPENS SUBSEQUENTLY IN AML WHEN CYTOGENETIC ABNORMALITIES PERSIST AT BONE-MARROW HARVEST - RESULTS OF THE 10TH UK MRC AML TRIAL, Bone marrow transplantation, 19(11), 1997, pp. 1117-1123
INFLUENCE OF GENETIC PREDISPOSITION TO THROMBOSIS ON NATURAL-HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors:
REES D
GRIMWADE D
LANGABEER S
BURNETT A
GOLDSTONE A
Citation: D. Rees et al., INFLUENCE OF GENETIC PREDISPOSITION TO THROMBOSIS ON NATURAL-HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA, British Journal of Haematology, 96(3), 1997, pp. 490-492
CHARACTERIZATION OF CRYPTIC REARRANGEMENTS AND VARIANT TRANSLOCATIONSIN ACUTE PROMYELOCYTIC LEUKEMIA
Authors:
GRIMWADE D
GORMAN P
DUPREZ E
HOWE K
LANGABEER S
OLIVER F
WALKER H
CULLIGAN D
WATERS J
POMFRET M
GOLDSTONE A
BURNETT A
FREEMONT P
SHEER D
SOLOMON E
Citation: D. Grimwade et al., CHARACTERIZATION OF CRYPTIC REARRANGEMENTS AND VARIANT TRANSLOCATIONSIN ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 90(12), 1997, pp. 4876-4885
Authors:
GRIMWADE D
LANGABEER S
GORMAN P
HOWE K
DUPREZ E
WALKER H
WHEATLEY K
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., MOLECULAR CHARACTERIZATION OF PATIENTS WITH APL ENTERED INTO THE UK MRC ATRA TRIAL - RELATIONSHIP OF PML BREAKPOINT WITH ADDITIONAL CYTOGENETIC ABNORMALITIES AND OUTCOME, Blood, 90(10), 1997, pp. 271-271
Authors:
GRIMWADE D
HOWE K
LANGABEER S
BURNETT A
GOLDSTONE A
SOLOMON E
Citation: D. Grimwade et al., MINIMAL RESIDUAL DISEASE DETECTION IN ACUTE PROMYELOCYTIC LEUKEMIA BYREVERSE-TRANSCRIPTASE PCR - EVALUATION OF PML-RAR-ALPHA AND RAR-ALPHA-PML ASSESSMENT IN PATIENTS WHO ULTIMATELY RELAPSE, Leukemia, 10(1), 1996, pp. 61-66
Authors:
GRATWOHL A
GORIN C
APPERLEY J
GOLDSTONE A
ROSTI G
BACIGALUPO A
GLUCKMAN E
FISCHER A
LJUNGMAN P
KOLB HJ
NIETHAMMER D
Citation: A. Gratwohl et al., THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT) - A REPORT FROM THE PRESIDENT AND THE CHAIRMEN OF THE WORKING PARTIES, Bone marrow transplantation, 18(4), 1996, pp. 677-691
Authors:
GRIMWADE D
HOWE K
LANGABEER S
DAVIES L
OLIVER F
WALKER H
SWIRSKY D
WHEATLEY K
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., ESTABLISHING THE PRESENCE OF THE T(15-17) IN SUSPECTED ACUTE PROMYELOCYTIC LEUKEMIA - CYTOGENETIC, MOLECULAR AND PML IMMUNOFLUORESCENCE ASSESSMENT OF PATIENTS ENTERED INTO THE MRC ATRA TRIAL, British Journal of Haematology, 94(3), 1996, pp. 557-573
Authors:
GRIMWADE D
DAVIES L
HOWE K
BODDY M
LANGABEER S
WALKER H
SMITH F
WHEATLEY K
SWIRSKY D
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., ESTABLISHING THE PRESENCE OF T(15-17) IN PATIENTS WITH SUSPECTED APL,ENTERED INTO THE MRC ATRA STUDY, BY PML IMMUNOFLUORESCENCE STAINING, British Journal of Haematology, 93, 1996, pp. 203-203
Authors:
GRIMWADE D
WALKER H
HARRISON C
OLIVER F
WHEATLEY K
HARRISON G
GRAY R
HANN I
STEVENS R
REES J
GOLDSTONE A
BURNETT A
Citation: D. Grimwade et al., IMPACT OF DIAGNOSTIC CYTOGENETICS ON OUTCOME IN AML - ANALYSIS OF 1,613 PATIENTS ENTERED INTO THE UK MRC AML 10 TRIAL, Blood, 88(10), 1996, pp. 2525-2525
Authors:
KIM YI
IZUMI F
KAMIYAMA T
TAKEDA Y
HIROI Z
TAKANO M
GOLDSTONE A
ONG E
Citation: Yi. Kim et al., STRUCTURAL STUDY OF LA1.93BI0.07CUO4+DELTA BY NEUTRON POWDER DIFFRACTION, Synthetic metals, 71(1-3), 1995, pp. 1629-1630
Authors:
GRIMWADE D
HOWE K
LANGABEER S
WALKER H
SMITH F
SWIRSKY D
WHEATLEY K
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., MOLECULAR AND CYTOGENETIC ASSESSMENT OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) ENTERED INTO THE UK MRC ATRA TRIAL, Blood, 86(10), 1995, pp. 1060-1060
Authors:
WHEATLEY K
BURNETT A
GOLDSTONE A
HANN I
STEVENS R
REES J
GRAY R
Citation: K. Wheatley et al., A SIMPLE, ROBUST AND HIGHLY PREDICTIVE PROGNOSTIC INDEX FOR THE DETERMINATION OF RISK DIRECTED THERAPY IN ACUTE MYELOID-LEUKEMIA (AML) DERIVED FROM THE UNITED-KINGDOM MEDICAL-RESEARCH-COUNCIL (MRC) AML10 TRIAL, Blood, 86(10), 1995, pp. 2381-2381
Authors:
GRATWOHL A
HERMANS J
PEARCE R
GORIN NC
APPERLEY J
DEWITTE T
GAHRTON G
SCHMITZ N
PHILIP T
ROSTI G
GOLDSTONE A
ERNST P
BACIGALUPO A
Citation: A. Gratwohl et al., HEMATOPOIETIC PRECURSOR CELL TRANSPLANTS - MAIN RISK-FACTORS, Blood, 86(10), 1995, pp. 2460-2460
Authors:
COLLINS P
RODERICK A
OBRIEN D
TUDDENHAM E
ODRISCOLL A
CHOPRA R
GOLDSTONE A
NEWLAND A
Citation: P. Collins et al., FACTOR VIIA AND OTHER HEMOSTATIC VARIABLES FOLLOWING BONE-MARROW TRANSPLANTATION, Thrombosis and haemostasis, 72(1), 1994, pp. 28-32
Authors:
COLLINS PW
RODERICK A
OBRIEN D
TUDDENHAM E
GOLDSTONE A
NEWLAND AC
Citation: Pw. Collins et al., BONE-MARROW TRANSPLANTATION IS NOT ASSOCIATED WITH INCREASED LEVELS OF FACTOR-VIIA, British Journal of Haematology, 84, 1993, pp. 53-53
Authors:
LINK H
FAUSER A
HUBNER G
BACIGALUPO A
BOOGAERTS M
BURDACH S
CARELLA A
FERRANT A
GOLDSTONE A
GORIN N
KRIEGER O
LINKESCH W
MANDELLI F
MCCANN S
REIFFERS J
SLAVIN S
STEWARD W
TURA S
ZINTL F
SCHINDELKUNZEL F
HEINRICHS H
Citation: H. Link et al., CLINICAL BONE-MARROW TRANSPLANTATION .3. RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION - A PROSPECTIVE PLACEBO-CONTROLLED TRIAL IN EUROPE, Blood, 82(10), 1993, pp. 10000284-10000284
Authors:
FRASSONI F
LABOPIN M
PALUTMZALI P
BUCHNER T
BURNETT A
CLINK HM
GLUCKMAN E
GOLDSTONE A
GRATWOHL A
HAGENBEEK A
HERVE P
LOWENBERG B
HOELTZER D
MANDELLI F
PRENTICE HG
RINGDEN O
RIZZOLI V
SCHATTEMBERG A
SIERRA J
TURA S
GORIN NC
Citation: F. Frassoni et al., EVOLUTION OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN EUROPE - IMPROVED RESULTS FOR PATIENTS WITH ACUTE-LEUKEMIA IN 1ST REMISSION, Blood, 82(10), 1993, pp. 10000291-10000291
Authors:
FRASSONI F
LABOPIN M
PALUTMZALI P
BUCHNER T
BURNETT A
CLINK HM
GLUCKMAN E
GOLDSTONE A
GRATWOHL A
HAGENBEEK A
HERVE P
LOWENBERG B
HOELTZER D
MANDELLI F
PRENTICE HG
RINGDEN O
RIZZOLI V
SCHATTEMBERG A
SIERRA J
TURA S
GORIN NC
Citation: F. Frassoni et al., RISK OF EVENTS BEYOND 2-YEARS FROM BONE-MARROW TRANSPLANT FOR ACUTE-LEUKEMIA IN EUROPE, Blood, 82(10), 1993, pp. 10000345-10000345
Risultati:
1-22
|